WASHINGTON, Aug. 1, 2016 /PRNewswire/ -- Durban, South Africa was once again the setting for the largest HIV/AIDS Conferences on global health and development issues in the world. This year's 21st International AIDS conference was a call to action to bring together people, lacking access to comprehensive treatment prevention, support and care and unite them with the theme, "No one must be left behind."
Dr. Gloria B. Herndon, President and CEO of GB Pharma Holdings, Washington, DC, was amongst the 17,000 prominent visitors at this year's July conference. During her meetings with the 'Champions for AIDS', made up of a group of former African Heads of State. President Joyce Banda of Malawi; lauded Dr. Herndon for her hard work and her successes with LodonalTM, the break-through drug, that has been approved to strengthen weakened immune systems compromised by HIV/AIDS.
President Banda told the audience that LodonalTM is a treatment regime that should be made available to all in need in Africa. "After successful trial and approval in Nigeria, Equatorial Guinea and Malawi," Dr. Herndon said, "GB Pharma is now able to do exactly that in Nigeria and beyond. LodonalTM is not only innovative, but it is also economically sustainable at about a $1 per day. Together in cooperation with Nigeria's Fidson Healthcare Plc, GB Pharma is positioned to guarantee that no one is left behind, and our hard work and excellent product will be used successfully at serving humanity."
During the four-day conference, which brought together prominent researchers, clinicians, policy and program planners, and public health and community practitioners, and international personalities like founding patrons Sir Elton John and Prince Harry, Dr. Herndon met with key champions for AIDS, UNAIDS and other organizations. In each of her meetings, she made a compassionate presentation on the positive effects of LodonalTM.
"We at GB Pharma are all extremely proud to be part of not only just a solution, but a strategic solution in the war against HIV/AIDS and other weakened immune system diseases."
GB Pharma Holdings is a global Pharmaceutical company with expertise in defining policies, facilitating approvals, distribution and GMP (Good Manufacturing Practices). Additionally, it is a comprehensive pharmaceutical management and consulting service agency, a wholesale pharmaceutical distributor, and a conduit for accessing quality international pharmaceutical and medical products.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/21st-international-aids-conference-durban-south-africa-gb-pharma-holdings-strategically-positions-itself-in-africa-for-distribution-and-contribution-to-reducing-hivaids-with-wonder-drug-lodonal-300306954.html
SOURCE GB Group Global